FDA expected to soon authorise Pfizer-BioNTech’s booster for 5- to 11-year-olds
FDA expected to soon authorise Pfizer-BioNTech’s booster for 5- to 11-year-olds
Indian Express
0 shares
1 views
You might like
Related news coverage
Pfizer Says 3-Dose COVID-19 Vaccine Is Effective For Children Under 5
Newsy
Watch VideoThree doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced..
Advertisement
More coverage
Kids 5 to 11 get FDA OK for COVID-19 booster doses
Ars Technica
CDC is expected to review boosters later this week and endorse their use.